Global editionEditorial standards
Laboratory markets
Symbols only · no quotes

LABORATORY SECTOR TODAY / INDEPENDENT

The businessof laboratories.

Capital moves.
Evidence matters.

Ownership, capacity and competitive change—across commercial, captive and public laboratories.

INDUSTRY PULSE
90D · THROUGH 2026-11-08 / 1 source-linked recordsLabcorp completed its acquisition of Millennium Health
Open intelligence desk Explore Signals

Selected archive, not market totals. Lines = 12 weekly record-count bins, not prices or growth. Colors identify research series, not evidence ratings.

THE EVIDENCE BEHIND THE SIGNAL

The evidence ledger

Laboratory business signals

2
dated acquisition recordsJul 5, 2022 — Nov 4, 2026
Recorded events by year · count, not deal value
102022: 1 dated source-linked records120222026: 1 dated source-linked records12026

Source-linked tracker & investor examples; not a market census or live feed. Dates reflect recorded events, not today's activity. Held articles excluded.

01 / OWNERSHIP & CAPITALResearch library
2Acquisition records
5Investor profiles
6Distress & legal records
0Dated expansion records

Selected source-linked examples.
Not industry totals.

Signals · Coverage density

The recorded evidence, quarter by quarter.

Source-linked record counts by quarter. Dash means no recorded evidence, not no market activity.
Research seriesQ1Q2Q3Q4
M&A
Investment
Pressure / legal
Expansion

Blue intensity = number of source-linked records, not risk or performance. — = no recorded evidence. This selected archive is not a market census; multiple milestones may concern one transaction.

Source ledger · 2026 (4)

  1. Labcorp completed its acquisition of Millennium HealthCompleted
  2. DermTech settlement gave the United States an allowed $5,038,011 unsecured bankruptcy claimSettled; no liability determination
  3. Access DX Laboratory and two individuals agreed to pay a combined $36.4M to settle kickback and genetic-testing allegationsSettled; Corporate Integrity Agreement
  4. South Carolina's former Labtech Diagnostics agreed to plead guilty and pay at least $6.8MCivil settlement; plea agreed

Your research agenda

Signals & Watches

Innovation topicOperations

AI & Automation

Robotic sample preparation, LIMS integration and AI validation. Distinguish documented workflows from vendor promises.

Emerging topicOperations

Hiring · 11+ openings

Research distinct employer openings and distinguish recruitment plans from actual hires. No checked 11-opening set is available; advertisements do not prove growth.

Research watchCapital

M&A

Dated acquisition records with buyer, target and transaction stage. An agreement, closing and integration are different milestones.

Research watchCapital

Investors

Source-linked laboratory ownership profiles and investment timelines. Historical transactions are not a complete current portfolio.

Emerging topicInstitutions

Construction & Expansion

Follow proposals, funding, commissioning and operational openings. New floor space does not establish new testing capacity.

Research watchCapital

Laboratories Under Pressure

Bankruptcies, documented recalls and enforcement records with exact entity, date and legal posture. Allegations are not findings; historical notices are not live alerts.

Research watchInstitutions

Government Labs

Federal, state, university and nonprofit laboratory research. Separate proposed budgets, enacted appropriations, awards and completed actions.

Research watchOperations

Standards & Accreditation

Scope, recognition and standards economics across commercial and captive laboratories. Verify the site and activity, not just the badge.

Research watchOperations

CLIA & Diagnostic Recalls

Certificate decisions, state licensing and product-lot recalls are distinct records. Historical FDA status is not a live safety alert.

Research watchOperations

Independent Lab Management

Transparent profitability, pricing and sales methods for commercial and captive laboratories. Blank formulas, not invented margin benchmarks.

Research watchInstitutions

Global Markets

Cross-border laboratory ownership and market-access research across China, India, Europe and Southeast Asia. Nationality is not a quality-risk proxy.

Your private company desk

Track the laboratory. Not just the ticker.

Create named lists of laboratory companies and institutions, keep private research notes and tags, and return to source-linked activity. No fabricated signals or unsolicited email.

Open company watchlists

Capital & ownership

Follow the transaction.
Know the stage.

Historical records, not a live deal feed. Read the announcement alongside the legal entity and completion status.

  1. Labcorp completed its acquisition of Millennium HealthCompleted
  2. Temasek: acquisition — Element Materials Technology (private)Completed
Open the M&A tracker

Risk & governance

Laboratories
Under Pressure

Bankruptcies, enforcement and diagnostic recalls. Exact entity, historical posture and last source check—not rumor or a live alert feed.

  1. DermTech settlement gave the United States an allowed $5,038,011 unsecured bankruptcy claimSettled; no liability determination · Source checked Nov 7, 2026
  2. Access DX Laboratory and two individuals agreed to pay a combined $36.4M to settle kickback and genetic-testing allegationsSettled; Corporate Integrity Agreement · Source checked Nov 7, 2026
Open Laboratories Under Pressure

The research desk

Find the company behind the signal.

Search public company profiles, sectors, source-linked research and approved reporting.

Executive Roundtable · Coming soon

A considered conversation.

For laboratory owners, executives, investors and scientists. Moderated discussion is planned; public posting is not open.

Register your interest

The Laboratory Sector Today briefing

Stay close to the evidence.

Save your daily or weekly preference. Email delivery is not configured; joining records consent only.

Frequency